Search
for
Sort by
Research 871–900 of 921
- A 36-Year-Old Woman With an Unexpected Cause of Hypokalemia
- Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts
- Endocrinology
- Role of Drug Repurposing in Sustainable Drug Discovery
- Natural Compound Isoliensinine Inhibits Stress-Induced Hair Greying by Blocking β2-Adrenoceptor
- Active Compounds with Medicinal Potential Found in Maxillariinae Benth. (Orchidaceae Juss.) Representatives—A Review
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- ISX9, a small molecule targeting Axin, activates Wnt/β-catenin signaling and promotes hair regrowth
- TGF-β Signaling: a Potential Therapeutic Target of Single Herbs and Extracts for Renal Fibrosis
- Repurposing of Various Current Medicines as Radioprotective Agents
- Hair Loss Associated with Sertraline: Two Case Reports and Review
- Oral Presentations
- Toxic and Metabolic Disorders of the Nervous System
- TACRINE
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- A Randomised Controlled Trial Comparing the Therapeutic Efficacy and Safety of Oral Cyclosporine and Oral Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- Adnexotropic Variants of the Interface Dermatitides: A Review
- Female pattern hair loss: therapeutic update
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation
- Development and Characterization of Hydrogel containing Finasteride
- Evaluation of the efficacy and safety of topical procyanidin b2 and placebo in the treatment of androgenetic alopecia in men; A randomized, double-blind, placebo-controlled study
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Effectiveness of the active ingredients (Capixyl, Procapil, and rosemary extract) of the Trust? tonic for the treatment of androgenetic alopecia in comparison to minoxidil
- Role of oral minoxidil in patterned hair loss
- Ethosomes: New Prospects in Transdermal Delivery
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Topical Application of Oleuropein Induces Anagen Hair Growth in Telogen Mouse Skin